share_log

Guggenheim Maintains Buy on HilleVax, Lowers Price Target to $34

Benzinga ·  Nov 15, 2023 14:02

Guggenheim analyst Seamus Fernandez maintains HilleVax (NASDAQ:HLVX) with a Buy and lowers the price target from $38 to $34.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment